EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy

Yoh-Ichiro Iwasa iD, Tomoyuki Nakajima, Kentaro Hori, Yoh Yokota, Ryosuke Kitoh, Takeshi Uehara iD, Yutaka Takumi

Biomolecules · 2023

DOI: 10.3390/biom13121685 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Biomolecules, 2023. Verfasst von Yoh-Ichiro Iwasa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shinshu Public Utility Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although anti-programmed death-1 (PD-1) antibody therapy improves the prognosis in patients with head and neck squamous cell carcinoma (HNSCC), some patients exhibit disease progression even after showing a good response to the treatment initially because of acquired resistance. Here, we aimed to reveal the dynamic changes in the tumor and tumor microenvironment (TME) in a 77-year-old man diagnosed with oral squamous cell carcinoma who developed acquired resistance after the administration of nivolumab using spatial transcriptomics. The results showed that, before immunotherapy, the activated pathways in the tumor area were mainly related to the cancer immune system, including antigen processing cross-presentation, interferon–gamma signaling, and the innate immune system. After immunotherapy, the activated pathways were mainly related to epigenetic modification, including RMTs methylate histone arginine and HDAC deacetylates histones. Before immunotherapy, the activated pathways in the TME were mainly related to the metabolism of proteins, including SRP-dependent co-translational protein targeting the membrane. After immunotherapy, the activated pathways in the TME were related to sensory perception and signal transduction. Our study revealed that epigenetic-modification-related pathways were mainly activated after establishing acquired resistance, suggesting that epigenetic modification in the tumor may prevent cancer immune system activation via the anti-PD-1 antibody.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsHead and Neck NeoplasmsMaleHumansAgedTumor MicroenvironmentTranscriptomeImmunotherapySquamous Cell Carcinoma of Head and Neck

Stichwörter der Autor:innen

acquired resistancedigital spatial profilinghead and neck cancerimmune checkpoint inhibitorimmunotherapyprogrammed death-ligand 1

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
  • Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

ORCID-Profile: Yoh-Ichiro Iwasa, Takeshi Uehara

Förderung

  • Shinshu Public Utility Foundation

Zitieren

APA

Iwasa, Y. I., Nakajima, T., Hori, K., Yokota, Y., Kitoh, R., Uehara, T., & Takumi, Y. (2023). A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy. Biomolecules. https://doi.org/10.3390/biom13121685

Vancouver

Iwasa YI, Nakajima T, Hori K, Yokota Y, Kitoh R, Uehara T, et al. A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy. Biomolecules. 2023. doi:10.3390/biom13121685

BibTeX
@article{Iwasa2023,
  author = {Iwasa, Yoh-Ichiro and Nakajima, Tomoyuki and Hori, Kentaro and Yokota, Yoh and Kitoh, Ryosuke and Uehara, Takeshi and Takumi, Yutaka},
  title = {A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13121685}
}
Kostenlos starten →